insights_auto
Why is BLRX up 6.06%?
Dive Deeperchevron_right
BLRX:NASDAQ
BioLine RX Ltd - ADR
$2.10
arrow_upward
+6.06%(+0.12) 1D
Oct 20, 12:15:41 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BLRX...
Open
$2.07
High
$2.11
Low
$2.07
Mkt. cap
11.24M
Avg. vol.
16.23K
Volume
1.70K
52-wk high
$3.95
52-wk low
$1.94
EPS
-$0.49
Beta
1.61
Shares outstanding
4.98M
No. of employees
22
Open
$2.07
High
$2.11
Low
$2.07
Mkt. cap
11.24M
Avg. vol.
16.23K
Volume
1.70K
52-wk high
$3.95
52-wk low
$1.94
EPS
-$0.49
Beta
1.61
Shares outstanding
4.98M
No. of employees
22
News stories
From web sources and news partners
Stocktwits
·
27 minutes ago
Stock Market Correction In Its ‘Final Innings,’ Says Morgan Stanley’s Investment Chief
ChartMill
·
48 minutes ago
S&P 500 Unusual Volume Movers for October 20
Yahoo Finance
·
21 minutes ago
Alnylam (ALNY): Can the RNAi Franchise Get it an Entry into the S&P 500 Index?
Insider Monkey
·
24 minutes ago
Okta (OKTA): Does the AI-Identity Turnaround Make It a Stronger S&P 500 Contestant?
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR